# Frequently Asked Questions — Developing Potential Cellular and Gene Therapy Products - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/frequently-asked-questions-developing-potential-cellular-and-gene-therapy-products/18812f43-d054-46e4-b040-2e02c42fb4a3

> FDA guidance document: Frequently Asked Questions — Developing Potential Cellular and Gene Therapy Products. Issue date: November 18, 2024. Get complete insights and analysis.

---

## Details

- Title: Frequently Asked Questions — Developing Potential Cellular and Gene Therapy Products
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2024-11-18
- Last Changed: 2024-11-25
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2024-D-4311">FDA-2024-D-4311</a>

## Related Documents

- [Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-to-reduce-the-risk-of-transfusion-transmitted-malaria-draft-guidance-for-industry/1eea49f3-76b0-45d6-81c4-4a91e8a41311)
- [Potency Assurance for Cellular and Gene Therapy Products](https://www.globalkeysolutions.net/guidances/guidance-document/potency-assurance-for-cellular-and-gene-therapy-products/2a9b0d81-9dd5-43cf-994c-ac0df102c216)
- [Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products](https://www.globalkeysolutions.net/guidances/guidance-document/manufacturing-changes-and-comparability-for-human-cellular-and-gene-therapy-products/b4919edd-67a6-490a-ab51-aa1a3c93944e)